CAITLIN MAUREEN CASEY

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family BEULAVILLE, NC NPI 1861069486

General Payments — all program years on this page

$1,296.30

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 75
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $439.42 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $439.4222

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $97.137
2022 $406.2626
2023 $353.4920
2024 $439.4222

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086772311 Novartis Pharmaceuticals Corporation $23.45 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100293794 Novo Nordisk Inc $13.19 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100324038 Novo Nordisk Inc $16.22 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100389667 Novo Nordisk Inc $17.47 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100589061 Novo Nordisk Inc $16.77 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106889263 ABBVIE INC. $15.65 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106889265 ABBVIE INC. $18.59 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106889267 ABBVIE INC. $33.41 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116199952 GlaxoSmithKline, LLC. $13.40 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117001150 Medtronic, Inc. $25.64 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117521967 Amgen Inc. $13.24 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128736982 SANOFI PASTEUR INC. $14.86 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131517945 PFIZER INC. $71.06 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131636362 PFIZER INC. $23.41 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135542881 Lilly USA, LLC $15.16 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135554446 Lilly USA, LLC $13.91 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135571910 Lilly USA, LLC $16.00 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135574162 Lilly USA, LLC $16.92 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135595274 Lilly USA, LLC $16.47 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135595276 Lilly USA, LLC $14.21 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141918158 Merck Sharp & Dohme LLC $13.52 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151154043 Phathom Pharmaceuticals, Inc. $16.87 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.